People: Regeneron Pharmaceuticals Inc (REGN.OQ)
16 Mar 2018
Dr. Neil Stahl, Ph.D., is Executive Vice President - Research and Development Sciences of the Company. He previously served as Senior Vice President, Research and Development Sciences from January 2007 to December 2014, as Senior Vice President, Preclinical Development and Biomolecular Sciences from December 2000 to December 2007, and as Vice President, Preclinical Development and Biomolecular Sciences from January 2000 to December 2000. He joined the Company in 1991. Before becoming Vice President, Biomolecular Sciences in July 1997, Dr. Stahl was Director, Cytokines and Signal Transduction. Dr. Stahl received his Ph.D. in Biochemistry from Brandeis University.
|Total Annual Compensation, USD||619,300|
|Restricted Stock Award, USD||--|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||10,366,100|
|Fiscal Year Total, USD||10,985,400|